
The Library
The Beta Agonist Lung Injury TrIal (BALTI) : prevention trial protocol
Tools
Perkins, Gavin D., Park, Daniel P., Alderson, Derek, Cooke, Matthew (Professor of clinical systems design), Smith, F. Gao (Fang Gao), Gates, Simon, Lamb, S. E. (Sallie E.), Mistry, Dipesh and Thickett, David R. (2011) The Beta Agonist Lung Injury TrIal (BALTI) : prevention trial protocol. Trials, Vol.12 (No.1). p. 79. doi:10.1186/1745-6215-12-79 ISSN 1745-6215.
![]()
|
PDF
WRAP_Perkins0170657-lb-210711_1745-6215-12-79.pdf - Published Version - Requires a PDF viewer. Download (329Kb) |
Official URL: http://dx.doi.org/10.1186/1745-6215-12-79
Abstract
Background: Acute lung injury complicates approximately 25-30% of subjects undergoing oesophagectomy.
Experimental studies suggest that treatment with beta agonists may prevent the development of acute lung injury by decreasing inflammatory cell infiltration, activation and inflammatory cytokine release, enhancing basal alveolar fluid clearance and improving alveolar capillary barrier function.
Methods/Design: The Beta Agonist Lung Injury TrIal (prevention) is a multi-centre, randomised, double blind,
placebo-controlled trial. The aim of the trial is to determine in patients undergoing elective transthoracic
oesphagectomy, if treatment with inhaled salmeterol 100 mcg twice daily started at induction of anaesthesia and
continued for 72 hours thereafter compared to placebo affect the incidence of early acute lung injury and other
clinical, resource and patient focused outcomes. The primary outcome will be the development of acute lung
injury within 72 hours of oesophagectomy. The trial secondary outcomes are the development of acute lung injury during the first 28 days post operatively; PaO2: FiO2 ratio; the number of ventilator and organ failure free days, 28 and 90 day survival; health related quality of life and resource utilisation. The study aims to recruit 360 patients from 10 UK centres.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RD Surgery R Medicine > RM Therapeutics. Pharmacology |
||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Library of Congress Subject Headings (LCSH): | Lungs -- Wounds and injuries -- Prevention, Esophagectomy -- Complications, Adrenergic beta agonists | ||||
Journal or Publication Title: | Trials | ||||
Publisher: | BioMed Central Ltd. | ||||
ISSN: | 1745-6215 | ||||
Official Date: | 15 March 2011 | ||||
Dates: |
|
||||
Volume: | Vol.12 | ||||
Number: | No.1 | ||||
Page Range: | p. 79 | ||||
DOI: | 10.1186/1745-6215-12-79 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Open Access (Creative Commons) | ||||
Date of first compliant deposit: | 17 December 2015 | ||||
Date of first compliant Open Access: | 17 December 2015 | ||||
Funder: | Intensive Care Society (Great Britain) (ICS), National Institute for Health Research (Great Britain) (NIHR) |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year